Cabaletta Share Price

Cabaletta Share Price

NASDAQ: CABA | Micro Cap | Healthcare
$1.08
+$0.07 (6.90%) Last updated on 19 Nov, 2026 | 00:58 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Cabaletta Stock Performance

Open
$1.04
Prev. Close
$1.01
Circuit Range
N/A
Day Range
$1.03 - $1.11
Year Range
$0.98 - $4.21
Volume
88,917
Average Traded
$1.09

Cabaletta Share Price Today

As of 19 November 2026, Cabaletta Bio, Inc.'s share price is $1.08. The stock opened at $1.04, compared to its previous close of $1.01. During today's trading session, Cabaletta Bio, Inc.'s share price traded between $1.03 and $1.11, with an average price of $1.07. Over the past 52 weeks, the stock has recorded a high of $4.21 and a low of $0.98. In terms of performance, Cabaletta Bio, Inc.'s share price has declined by 71.37% over the last six months and is down 57.62% on a year-on-year basis.

Cabaletta Share Price Chart

Line chart of the Cabaletta price trend over the selected period. The price rose overall, ranging from 1.03 to 1.11, ending at 1.08.
$1.03$1.11
L
Show Current Price
H

Cabaletta Stock Fundamentals & Key Indicators

Market Cap
$86.73M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.88
Revenue (TTM)
$0.00
Return On Equity (TTM)
-66.75%
Profit Margin
N/A
Debt to Equity
0.06
Quarterly Earnings Growth YoY
-26.55%

Cabaletta Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$41.92-$43.52-$51.02-$53.05
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-3.82%-17.23%-3.98%

Cabaletta Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$52.98-$67.68-$114.73-$167.86
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-27.75%-69.52%-46.31%

Cabaletta Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets26.2118.379.168.13
Current Assets138.87166.68244.49108.83
Total Assets165.08185.05253.65116.97
Non Current Liabilities2.885.631.462.96
Current Liabilities50.1527.0915.999.49
Total Liabilities53.0332.7117.4512.45
Shareholders' Equity112.05152.34236.2104.52

Cabaletta Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-131.08-88.22-53.55-46.38
Investing-50.2747.29-22.45-27.22
Financing100.3511.68187.6332.98

About Cabaletta

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

Cabaletta Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.52
$1.08
-27.91%
Oct 2026
$1.91
$1.50
-21.61%
Sep 2026
$2.98
$1.92
-43.53%
Aug 2026
$2.65
$3.40
+26.39%
Jul 2026
$3.12
$2.69
-13.78%
Jun 2026
$3.79
$3.12
-17.68%
May 2026
$2.90
$3.79
+26.97%
Apr 2026
$2.70
$2.98
+11.17%
Mar 2026
$3.21
$2.69
-19.37%
Feb 2026
$2.52
$3.33
+30.08%
Jan 2026
$2.15
$2.56
+16.63%
Dec 2025
$2.46
$2.19
-14.26%

Cabaletta Share Price FAQs